16.42
price down icon6.76%   -1.19
after-market Handel nachbörslich: 16.28 -0.14 -0.85%
loading

Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten

pulisher
Nov 18, 2024

MBX Biosciences (NYSE:MBX) Shares Gap UpTime to Buy? - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

MBX Biosciences Announces Last Subject Last Visit in Phase - GlobeNewswire

Nov 18, 2024
pulisher
Nov 17, 2024

MBX Biosciences (NYSE:MBX) Reaches New 12-Month Low – Here’s Why - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

MBX Biosciences (NYSE:MBX) Sets New 1-Year LowWhat's Next? - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

MBX Biosciences: Decent Potential For Lead Indication, But Need More Data (NASDAQ:MBX) - Seeking Alpha

Nov 14, 2024
pulisher
Nov 11, 2024

MBX Biosciences (NYSE:MBX) Shares Gap DownHere's What Happened - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

MBX Biosciences Reports Q3 2024 Financial Progress - MSN

Nov 09, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP Acquires New Stake in MBX Biosci - GuruFocus.com

Nov 08, 2024
pulisher
Nov 07, 2024

MBX Biosciences Inc. (MBX) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

MBX Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

MBX Biosciences Secures $251M in IPO, Advances Clinical Pipeline with Strong Cash Position | MBX Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 05, 2024

MBX Biosciences (NYSE:MBX) Shares Up 8.2%Time to Buy? - MarketBeat

Nov 05, 2024
pulisher
Oct 29, 2024

MBX Biosciences (NYSE:MBX) Shares Up 6.8%Should You Buy? - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

MBX Biosciences (NYSE:MBX) Sets New 52-Week LowTime to Sell? - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

MBX Biosciences to Participate in Upcoming November Investor Conferences - The Manila Times

Oct 28, 2024
pulisher
Oct 25, 2024

MBX Biosciences (NYSE:MBX) Shares Down 4.5%Here's What Happened - MarketBeat

Oct 25, 2024
pulisher
Oct 18, 2024

MBX Biosciences sets IPO terms with plans to raise up to $136 million - MSN

Oct 18, 2024
pulisher
Oct 16, 2024

MBX Biosciences, Inc.'s (NYSE:MBX) Quiet Period To End on October 23rd - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

MBX Biosciences, Inc.’s Quiet Period Set To Expire on October 23rd (NYSE:MBX) - Defense World

Oct 16, 2024
pulisher
Oct 14, 2024

MBX Biosciences (NYSE:MBX) Stock Price Down 4%Here's Why - MarketBeat

Oct 14, 2024
pulisher
Oct 10, 2024

MBX Bio drops despite bullish views on Street - MSN

Oct 10, 2024
pulisher
Oct 10, 2024

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - BNN Bloomberg

Oct 10, 2024
pulisher
Oct 09, 2024

MBX Biosciences (NYSE:MBX) Shares Up 4.6%Here's What Happened - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

MBX Biosciences earns Buy rating at three investment firms - MSN

Oct 08, 2024
pulisher
Oct 08, 2024

MBX Bio stock drops despite bullish initiations (NASDAQ:MBX) - Seeking Alpha

Oct 08, 2024
pulisher
Oct 08, 2024

Guggenheim bullish on MBX Biosciences stock, driven by MBX 2109 potential - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

MBX Biosciences outlook solid with JPMorgan's overweight rating, eyes key catalysts in next 12 months - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

Jefferies sees upside in MBX Biosciences stock, highlights PEP platform advancements - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

MBX Biosciences earns Buy rating at three investment firms By Investing.com - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Guggenheim Begins Coverage on MBX Biosciences (NYSE:MBX) - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

MBX Biosciences (NYSE:MBX) Now Covered by JPMorgan Chase & Co. - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Jefferies sees upside in MBX Biosciences stock, highlights PEP platform advancements By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 04, 2024

MBX Biosciences (NYSE:MBX) Stock Price Down 3.5%Should You Sell? - MarketBeat

Oct 04, 2024
pulisher
Sep 30, 2024

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ - GlobeNewswire

Sep 30, 2024
pulisher
Sep 30, 2024

MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting - Yahoo Finance

Sep 30, 2024
pulisher
Sep 28, 2024

MBX Biosciences (NYSE:MBX) Trading Down 4.1% - MarketBeat

Sep 28, 2024
pulisher
Sep 24, 2024

MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - PR Newswire

Sep 24, 2024
pulisher
Sep 23, 2024

HighVista Strategies LLC Lowers Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Lelezard

Sep 23, 2024
pulisher
Sep 23, 2024

330 Shares in Monolithic Power Systems, Inc. (NASDAQ:MPWR) Bought by Brighton Jones LLC - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Westwood Holdings Group Inc. Grows Holdings in Mplx Lp (NYSE:MPLX) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Hagens Berman Reminds MacroGenics (MGNX) Investors of the Pending Class Action Lawsuit with a Lead Plaintiff - EIN News

Sep 21, 2024
pulisher
Sep 21, 2024

MGNX Deadline: MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit - Lelezard

Sep 21, 2024
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):